[Show abstract][Hide abstract] ABSTRACT: In October 2010, one case of autochthonous malaria due to Plasmodium vivax was diagnosed in Spain. The case occurred in Aragon, north-eastern Spain, where the vector Anopheles atroparvus is present. Although the source of infection could not be identified, this event highlights that sporadic autochthonous transmission of vector-borne diseases in continental Europe is possible and calls for enhanced surveillance and vector control measures.
Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 01/2010; 15(41):19684. · 5.49 Impact Factor
[Show abstract][Hide abstract] ABSTRACT: We describe the clinical and epidemiological characteristics of patients hospitalised with confirmed 2009 pandemic influenza A(H1N1) in Spain from April to December 2009 and the risk factors associated with a worse outcome (admission to an intensive care unit or death) in adults. Case-based epidemiological information was collected as part of the national strategy for the surveillance of severe cases. Of 3,025 patients, 852 were admitted to an intensive care unit and overall, 200 died. The median patient age was 38 years (range: 0–94). A total of 662 (26%) patients had no underlying risk conditions. Antiviral therapy was initiated within 48 hours after symptom onset in only 35.2% (n=711); the median length of time before treatment was four days. In a multivariate analysis, the start of antiviral therapy more than 48 hours after symptom onset (odds ratio (OR) 2.39; 95% confidence interval (CI): 1.79 to 3.2), morbid obesity (OR: 2.01; 95% CI 1.38 to 2.94), cardiovascular disease (OR: 1.79; 95% CI: 1.2 to 2.67) and chronic obstructive pulmonary disease (OR: 1.51; 95% CI: 1.03 to 2.2) were significantly associated with a worse outcome in adults.
Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin 01/2010; 15(38). · 5.49 Impact Factor
[Show abstract][Hide abstract] ABSTRACT: This study aimed at describing influenza vaccination coverage among Spanish children, adults and health care workers (HCWs).
We analyzed 27,791 questionnaires on subjects aged 6 months or over, drawn from the 2003 Spanish National Health Survey. As the dependent variable, we took the answer to the question, "Did you (or your child) have a flu shot in the last campaign?". Independent variables were age group, gender, nationality, occupation (HCWs) and coexistence of chronic conditions.
Overall influenza vaccination coverage for the total sample was 19.58%. Coverage for the pediatric population was 5.55%, with 20.74% of those with and 4.67% of those without chronic condition being vaccinated. Vaccination coverages were: 63.7% among subjects aged > or = 65 years; 30.5% among high-risk subjects aged < 65 years; and 19.65% among HCWs.
We conclude that the available results show low levels of influenza vaccination coverage among high-risk subjects aged under 65 years, children in particular, and HCWs.
[Show abstract][Hide abstract] ABSTRACT: The objective of this study is to describe the evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. We analysed 55,040 questionnaires taken from the Spanish National Health Surveys from the years 1993, 1995, 1997 and 2001. The reply to the question "Did you vaccinate yourself against influenza during the last campaign?" is the dependent variable. Independent variables were the year of the survey, age, sex and the coexistence of chronic conditions. After adjusting using logistic regression, we found a significant improvement during the study period among those subjects at risk of suffering complications from influenza (OR 1.21). Nevertheless, this increase was essentially at the cost of subjects aged 65 and over. Subjects with high-risk conditions under 65 did not undergo significant changes. CONCLUSIONS:A significant but insufficient improvement has been achieved and this must lead us to consider the possible need to modify anti-influenza vaccination recommendations.